RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Artificial intelligence powered radiomics model for the assessment of colorectal tumor immune microenvironment.
Artificial intelligence powered radiomics model for the assessment of colorectal tumor immune microenvironment.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
Zhou等人发表在World Journal of Gastrointestinal Oncology上的关于利用术前计算机断层扫描(CT)影像组学创建无创深度学习(DL)方法用于结直肠肿瘤免疫微环境评估的研究是全面且科学的。
该研究分析了315例确诊结直肠癌患者的术前CT图像,使用手动感兴趣区提取DL特征。该研究利用CT图像和组织病理学图像开发了一个DL模型,用于预测结直肠癌患者的免疫相关指标。病理学参数(肿瘤-间质比、TIL(肿瘤浸润淋巴细胞)浸润、免疫组织化学、肿瘤免疫微环境和免疫评分)与影像组学数据(CT成像和模型构建)相结合,生成了人工智能驱动的模型。使用受试者工作特征曲线、曲线下面积和决策曲线分析评估了模型的临床获益和拟合优度。所开发的基于DL的影像组学预测模型用于无创评估肿瘤标志物,在结直肠癌患者的个体化治疗计划和免疫治疗策略方面显示出潜力。
该研究仅涉及来自单一医疗中心的小样本群体,缺乏纳入/排除标准,并且应纳入临床病理学特征,以获得对结直肠癌患者有价值的治疗实践见解。
Zhou et al 's investigation on the creation of a non-invasive deep learning (DL) method for colorectal tumor immune microenvironment evaluation using preoperative computed tomography (CT) radiomics published in the World Journal of Gastrointestinal Oncology is thorough and scientific. The study analyzed preoperative CT images of 315 confirmed colorectal cancer patients, using manual regions of interest to extract DL features. The study developed a DL model using CT images and histopathological images to predict immune-related indicators in colorectal cancer patients. Pathological (tumor-stroma ratio, tumor-infiltrating lymphocytes infiltration, immunohistochemistry, tumor immune microenvironment and immune score) parameters and radiomics (CT imaging and model construction) data were combined to generate artificial intelligence-powered models.
Clinical benefit and goodness of fit of the models were assessed using receiver operating characteristic, area under curve and decision curve analysis. The developed DL-based radiomics prediction model for non-invasive evaluation of tumor markers demonstrated potential for personalized treatment planning and immunotherapy strategies in colorectal cancer patients.
The study, involving a small group from a single medical center, lacks inclusion/exclusion criteria and should include clinicopathological features for valuable therapeutic practice insights in colorectal cancer patients.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。